Every few years, the pharmaceutical industry quietly reminds the market of an uncomfortable truth: the biggest value creation doesn’t always come from discovering a brand-new drug. Sometimes, it comes ...

Glucagon is indicated for the treatment of severe hypoglycemia in patients with diabetes mellitus and as a diagnostic aid for use during certain radiologic examinations. Lupin is introducing glucagon ...

It often occurs due to excess insulin, whether it's produced by your body or if you've injected too much of it. There are ways to treat it quickly, but if hypoglycemia strikes when you're asleep, or ...

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low -- from taking too much insulin or not eating enough sugar -- people can experience hypoglycemia, ...

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low - from taking too much insulin or not eating enough sugar - people can experience hypoglycemia, ...

Encapsulated glucagon for insulin-induced hypoglycemia dissolves when sugar levels get seriously low (less than 60 milligrams per deciliter, mg/dL), releasing the hormone into the bloodstream and ...

Bausch + Lomb and its subsidiary, Synergetics, recently announced the recall of certain lots of its I-Pack Injection Kits after the companies received information of potential non-sterility of the ...

AMPH has materially benefited from a variety of temporary factors across their key product lines that have largely gone unnoticed by investors, sending shares up ~100% over the last 3yrs. Amphastar’s ...

Seeking Alpha's screener identified Amphastar Pharmaceuticals as a potential investment candidate based on its solid financials, positive growth in revenue and earnings. Despite its strong financials ...